Title:
OPHTHALMIC COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2023/073925
Kind Code:
A1
Abstract:
A first aspect of the present invention relates to an ophthalmic composition for suppressing the dryness of the eyes, the ophthalmic composition containing at least one component selected from the group consisting of chondroitin sulfate having a weight average molecular weight of 40,000 to 70,000 and salts thereof. A second aspect of the present invention relates to an ophthalmic composition comprising at least one component selected from the group consisting of chondroitin sulfate having a weight average molecular weight of 40,000 to 70,000 and salts thereof and at least one component selected from the group consisting of an antihistaminic agent, a zinc salt, tetrahydrozoline and salts thereof, hydroxyethyl cellulose and salts thereof and a polyvinyl-based polymeric compound. A third aspect of the present invention relates to an ophthalmic composition comprising at least one component selected from the group consisting of chondroitin sulfate having a weight average molecular weight of 40,000 to 70,000 and salts thereof and menthol.
Inventors:
ANDO TATSUYA (JP)
MITSUGUCHI YOKO (JP)
MATSUMOTO SACHIKO (JP)
NAKATA ATSUKO (JP)
KIYOBAYASHI YUKA (JP)
MITSUGUCHI YOKO (JP)
MATSUMOTO SACHIKO (JP)
NAKATA ATSUKO (JP)
KIYOBAYASHI YUKA (JP)
Application Number:
PCT/JP2021/040030
Publication Date:
May 04, 2023
Filing Date:
October 29, 2021
Export Citation:
Assignee:
ROHTO PHARMA (JP)
International Classes:
A61K31/737; A61K47/36; A61P27/02
Domestic Patent References:
| WO2021220712A1 | 2021-11-04 |
Foreign References:
| JP2006193521A | 2006-07-27 | |||
| JP2013525335A | 2013-06-20 | |||
| JP2011148791A | 2011-08-04 |
Other References:
NAGANO ET AL., NEW OPHTHALMOLOGY, vol. 13, no. 2, 1996, pages 267 - 270
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Download PDF: